Roles
- Professor of Ophthalmology
-
Biography
After completion of her ophthalmology residency at Baylor College of Medicine, Dr. Janet Davis undertook fellowships in Vitreoretinal Surgery at Bascom Palmer Eye Institute and in Ocular Immunology at the NEI Laboratory of Immunology under the late Dr. Robert Nussenblatt. Currently she is the Leach Distinguished Professor of Ophthalmology at University of Miami Miller School of Medicine Bascom Palmer Eye Institute.
Her academic career includes numerous national and international lectures. She has participated in multi-center clinical trials as well as Phase I and II trials for drug development and surgical implantation of devices, stem cells, and gene therapy. Past leadership positions include chairman of American Board of Ophthalmology 2013, president of American Uveitis Society 2006-2008, and president of the International Uveitis Study Group 2013-2017. Honors include the AAO Lifetime Achievement and Secretariat Awards, Silver Fellow of ARVO, Retina Hall of Fame, a Castle Connelly Top Doctor and The Ophthalmologist Power List 2021 and 2023. She is a member of the Retina Society, Macula Society, International Ocular Inflammation Society and the American Ophthalmological Society. She participated in the AOS theses review committee from 2016-2019. She has published 45 book chapters and 260+ peer-reviewed articles on management and diagnostic techniques for lymphoma and uveitis, gene therapy, intraocular infections, macular degeneration, and several review articles. She is an Associate Editor for the American Journal of Ophthalmology. -
Teaching Interests
All aspects of diagnosis and management of intraocular infections and inflammations as well as masquerade conditions such as infiltrative or degenerative diseases. -
Research Interests
Diagnosis, treatment and disease mechanisms of intraocular inflammations and infections -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Articles & News
In Prestigious Jackson Memorial Lecture, Bascom Palmer Eye Institute Expert Calls for a New Era of Uveitis Care
Shaping the Future of Eye Care
Phase 3 Study on Gene Therapy for Inherited Retinal Disease Choroideremia Offers Important Insight
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 4 clinical trials.
-
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
- Principal Investigator: Janet Davis
- Study Phase: Phase 3
- Enrollment Status: Closed
-
This is a open-label, prospective study that will collect ocular fluid and blood from patients with uveitis to define the immunologic cellular and extracellular constituents in intraocular fluid and blood of patients with uveitis.
- Principal Investigator: Janet Davis
- Study Phase: N/A
- Enrollment Status: Closed
-
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
- Principal Investigator: Janet Davis
- Study Phase: Phase 3
- Enrollment Status: Closed
-
Multicenter, block-randomized, double-masked, placebo-controlled trial tocompare the safety and efficacy of stopping adalimumab treatment versuscontinuing adalimumab treatment in patients with uveitis associated withjuvenile idiopathic arthritis (JIA)
- Principal Investigator: Janet Davis
- Study Phase: Phase IV
- Enrollment Status: Not Accepting
